血糖监测市场 - 增长、趋势、COVID-19 影响和预测(2022 - 2027 年)

市场按类型(自我监测血糖和连续血糖监测)、组件(血糖仪设备、试纸、柳叶刀、传感器和接收器)和地理位置进行细分。

市场快照

Blood Glucose Monitoring Market
Study Period: 2016-2027
Base Year: 2021
Fastest Growing Market: North America
Largest Market: North America
CAGR: 9.6 %
Blood Glucose Monitoring Market Growth

Need a report that reflects how COVID-19 has impacted this market and its growth?

市场概况

在 2021-2026 年的预测期内,血糖监测市场的复合年增长率预计为 9.6%。到 2026 年,市场价值估计将达到 272 亿美元,这是由于 2 型糖尿病人群中监测设备的使用增加。血糖监测设备用于有效的糖尿病诊断和治疗。糖尿病人口的增加通过增加血糖监测设备的使用来推动市场。肥胖也被认为是导致该疾病的主要因素之一,主要是 2 型糖尿病。此外,其他因素,如技术创新和进步,为测量血糖水平提供了许多便利。在监测血糖水平方面的一项进步是通过连续血糖监测设备建立的。这些设备有助于及早发现低血糖和高血糖状况。这种青睐有望推动血糖监测市场。

报告范围

本研究包括两种主要类型的血糖监测设备,即自我监测血糖设备和连续血糖监测设备。这些设备进一步按组件分类,即自我监测血糖(SMBG)设备分为血糖仪设备、试纸、柳叶刀,而连续血糖监测(CGM)设备分为传感器和接收器。

Self-monitoring blood glucose devices (Value and Volume, 2016 - 2026)
By Component
Glucometer Devices
Test Strips
Lancets
Continuous blood glucose monitoring devices (Value and Volume, 2016 - 2026)
By Component
Sensors
Durables (Receivers and Transmitters)
Geography
North America
United States (Value and Volume, 2016 - 2026)
Self-monitoring Blood Glucose Devices
By Component (Glucometer Device, Test strips, Lancets)
Continuous Glucose Monitoring devices
By Component (Sensors and Receivers)
Canada (Value and Volume, 2016 - 2026)
Self-monitoring blood glucose devices
By Component (Glucometer Device, Test strips, and Lancets)
Continuous Glucose Monitoring
By Component (Sensors and Receivers)
Rest of North America (Value and Volume, 2016 - 2026)
Self-monitoring blood glucose devices
By Component (Glucometer Device, Test strips, and Lancets)
Continuous Glucose Monitoring
By Component (Sensors and Receivers)
Europe
France (Value and Volume, 2016 - 2026)
Self-monitoring Blood Glucose Devices
By Component (Glucometer Device, Test strips, and Lancets)
Continuous Glucose Monitoring
By Component (Sensors and Receivers)
Germany (Value and Volume, 2016 - 2026)
Self-monitoring Blood Glucose Devices
By Component (Glucometer Device, Test strips, and Lancets)
Continuous Glucose Monitoring
By Component (Sensors and Receivers)
Italy (Value and Volume, 2016 - 2026)
Self-monitoring blood glucose devices
By Component (Glucometer Device, Test strips, and Lancets)
Continuous Glucose Monitoring
By Component (Sensors and Receivers)
Spain (Value and Volume, 2016 - 2026)
Self-monitoring blood glucose devices
By Component (Glucometer Device, Test strips, and Lancets)
Continuous Glucose Monitoring
By Component (Sensors and Receivers)
United Kingdom (Value and Volume, 2016 - 2026)
Self-monitoring blood glucose devices
By Component (Glucometer Device, Test strips, and Lancets)
Continuous Glucose Monitoring
By Component (Sensors and Receivers)
Russia (Value and Volume, 2016 - 2026)
Self-monitoring blood glucose devices
By Component (Glucometer Device, Test strips, and Lancets)
Continuous Glucose Monitoring
By Component (Sensors and Receivers)
Rest of Europe (Value and Volume, 2016 - 2026)
Self-monitoring blood glucose devices
By Component (Glucometer Device, Test strips, and Lancets)
Continuous Glucose Monitoring
By Component (Sensors and Receivers)
Latin America
Mexico (Value and Volume, 2016 - 2026)
Self-monitoring Blood Glucose Devices
By Component (Glucometer Device, Test strips, and Lancets)
Continuous Glucose Monitoring
By Component (Sensors and Receivers)
Brazil (Value and Volume, 2016 - 2026)
Self-monitoring Blood Glucose Devices
By Component (Glucometer Device, Test strips, and Lancets)
Continuous Glucose Monitoring
By Component (Sensors and Receivers)
Rest of Latin America (Value and Volume, 2016 - 2026)
Self-monitoring Blood Glucose Devices
By Component (Glucometer Device, Test strips, and Lancets)
Continuous Glucose Monitoring
By Component (Sensors and Receivers)
Asia-Pacific
Japan (Value and Volume, 2016 - 2026)
Self-monitoring Blood Glucose Devices
By Component (Glucometer Device, Test strips, and Lancets)
Continuous Glucose Monitoring
By Component (Sensors and Receivers)
South Korea (Value and Volume, 2016 - 2026)
Self-monitoring Blood Glucose Devices
By Component (Glucometer Device, Test strips, and Lancets)
Continuous Glucose Monitoring
By Component (Sensors and Receivers)
China (Value and Volume, 2016 - 2026)
Self-monitoring Blood Glucose Devices
By Component (Glucometer Device, Test strips, and Lancets)
Continuous Glucose Monitoring
By Component (Sensors and Receivers)
India (Value and Volume, 2016 - 2026)
Self-monitoring Blood Glucose Devices
By Component (Glucometer Device, Test strips, and Lancets)
Continuous Glucose Monitoring
By Component (Sensors and Receivers)
Australia (Value and Volume, 2016 - 2026)
Self-monitoring Blood Glucose Devices
By Component (Glucometer Device, Test strips, and Lancets)
Continuous Glucose Monitoring
By Component (Sensors and Receivers)
Vietnam (Value and Volume, 2016 - 2026)
Self-monitoring Blood Glucose Devices
By Component (Glucometer Device, Test strips, and Lancets)
Continuous Glucose Monitoring
By Component (Sensors and Receivers)
Malaysia (Value and Volume, 2016 - 2026)
Self-monitoring Blood Glucose Devices
By Component (Glucometer Device, Test strips, and Lancets)
Continuous Glucose Monitoring
By Component (Sensors and Receivers)
Indonesia (Value and Volume, 2016 - 2026)
Self-monitoring Blood Glucose Devices
By Component (Glucometer Device, Test strips, and Lancets)
Continuous Glucose Monitoring
By Component (Sensors and Receivers)
Philippines (Value and Volume, 2016 - 2026)
Self-monitoring Blood Glucose Devices
By Component (Glucometer Device, Test strips, and Lancets)
Continuous Glucose Monitoring
By Component (Sensors and Receivers)
Thailand (Value and Volume, 2016 - 2026)
Self-monitoring Blood Glucose Devices
By Component (Glucometer Device, Test strips, and Lancets)
Continuous Glucose Monitoring
By Component (Sensors and Receivers)
Rest of Asia-Pacific (Value and Volume, 2016 - 2026)
Self-monitoring Blood Glucose Devices
By Component (Glucometer Device, Test strips, and Lancets)
Continuous Glucose Monitoring
By Component (Sensors and Receivers)
Middle-East and Africa
Saudi Arabia (Value and Volume, 2016 - 2026)
Self-monitoring Blood Glucose Devices
By Component (Glucometer Device, Test strips, and Lancets)
Continuous Glucose Monitoring
By Component (Sensors and Receivers)
Iran (Value and Volume, 2016 - 2026)
Self-monitoring Blood Glucose Devices
By Component (Glucometer Device, Test strips, and Lancets)
Continuous Glucose Monitoring
By Component (Sensors and Receivers)
Egypt (Value and Volume, 2016 - 2026)
Self-monitoring Blood Glucose Devices
By Component (Glucometer Device, Test strips, and Lancets)
Continuous Glucose Monitoring
By Component (Sensors and Receivers)
Oman (Value and Volume, 2016 - 2026)
Self-monitoring Blood Glucose Devices
By Component (Glucometer Device, Test strips, and Lancets)
Continuous Glucose Monitoring
By Component (Sensors and Receivers)
South Africa (Value and Volume, 2016 - 2026)
Self-monitoring Blood Glucose Devices
By Component (Glucometer Device, Test strips, and Lancets)
Continuous Glucose Monitoring
By Component (Sensors and Receivers)
Rest of Middle-East and Africa (Value and Volume, 2016 - 2026)
Self-monitoring Blood Glucose Devices
By Component (Glucometer Device, Test strips, and Lancets)
Continuous Glucose Monitoring
By Component (Sensors and Receivers)

Report scope can be customized per your requirements. Click here.

主要市场趋势

血糖仪耗材市场占有率最高

尽管 CGM 是糖尿病患者实时检查血糖读数的一种先进方法,但 SMBG 是患者最喜欢的设备,因为与 CGM 相比,SMBG 经济实惠且使用复杂度较低。SBGM设备占据了血糖监测市场68%以上的份额。由于使用案例频率的差异,预计试纸的市场容量和份额的增长将高于血糖仪。血糖仪的平均效率在六个月到三年之间,而试纸是一次性使用的。由于在预测期内接受率预计会上升,预计对用户造成较少痛苦的新型柳叶刀装置的推出将有助于市场的增长。

Blood Glucose Monitoring Market Trends

北美引领市场

2020年,北美尤其是美国占血量最大份额 血糖监测市场,由于庞大的患者群体和对先进技术的广泛接受,欧洲紧随其后,增长适中。根据美国糖尿病协会 (ADA) 的数据,2018 年,3420 万美国人或 10.5% 的人口患有糖尿病。近 160 万美国人患有 1 型糖尿病,其中包括约 187,000 名儿童和青少年。在美国,在糖尿病行业拥有约 29 亿资金的初创公司有新的创新,如 Glooko、OneDrop、verily、Vacate、Insulet、Noom、Bigfoot Biomedical、Virta Health、Diabeloop、Orgenesis 等。在糖尿病领域联手带来的新技术正在增加预测期内的市场,例如,2020 年 7 月,Medtronic PLC 和 Tandem Diabetes Care Inc.

 Blood Glucose Monitoring Market Size

竞争格局

血糖监测市场高度分散,市场上几乎没有主要制造商。近期参与者之间的并购有助于这些公司加强其市场占有率。例如,2020 年 9 月,Insulet Corporation 及其 Omnipod 胰岛素管理系统(Omnipod System)宣布将在其他国家商业推出其 Omnipod DASH 胰岛素管理系统(Omnipod DASH System)。Omnipod DASH 系统现已在瑞典、芬兰、挪威和丹麦推出,未来几周将在法国、比利时、德国、奥地利、瑞士和以色列推出。

RECENT DEVELOPMENTS

In Feb 2021, Roche announced the launch of the new Accu-Chek Instant system, a new "connected" blood glucose monitoring (BGM) system, which supports and enables Roche’s approach of integrated Personalised Diabetes Management (iPDM). Accu-Chek Instant features Bluetooth-enabled connectivity to the mySugr app, allowing wireless transfer of blood glucose results to the mySugr app.

In Aug 2021, HAGAR, the developer of GWave technology that uses RF waves to measure glucose levels in the blood. HAGAR announced a USD 11.7 million Series B funding round led by a returning investor, Columbia Pacific. This round’s funding will be used for upcoming trials for Federal Drug Administration (FDA) approval, it will also be used for completing international patents.

Table of Contents

  1. 1. INTRODUCTION

    1. 1.1 Study Assumptions

    2. 1.2 Scope of the Study

  2. 2. RESEARCH METHODOLOGY

  3. 3. EXECUTIVE SUMMARY

  4. 4. MARKET DYNAMICS

    1. 4.1 Market Overview

    2. 4.2 Drivers

    3. 4.3 Restraints

    4. 4.4 Porter's Five Forces Analysis

      1. 4.4.1 Bargaining Power of Suppliers

      2. 4.4.2 Bargaining Power of Consumers

      3. 4.4.3 Threat of New Entrants

      4. 4.4.4 Threat of Substitute Products and Services

      5. 4.4.5 Intensity of Competitive Rivalry

  5. 5. MARKET SEGMENTATION

    1. 5.1 Self-monitoring blood glucose devices (Value and Volume, 2016 - 2026)

      1. 5.1.1 By Component

        1. 5.1.1.1 Glucometer Devices

        2. 5.1.1.2 Test Strips

        3. 5.1.1.3 Lancets

    2. 5.2 Continuous blood glucose monitoring devices (Value and Volume, 2016 - 2026)

      1. 5.2.1 By Component

        1. 5.2.1.1 Sensors

        2. 5.2.1.2 Durables (Receivers and Transmitters)

    3. 5.3 Geography

      1. 5.3.1 North America

        1. 5.3.1.1 United States (Value and Volume, 2016 - 2026)

          1. 5.3.1.1.1 Self-monitoring Blood Glucose Devices

            1. 5.3.1.1.1.1 By Component (Glucometer Device, Test strips, Lancets)

          2. 5.3.1.1.2 Continuous Glucose Monitoring devices

            1. 5.3.1.1.2.1 By Component (Sensors and Receivers)

        2. 5.3.1.2 Canada (Value and Volume, 2016 - 2026)

          1. 5.3.1.2.1 Self-monitoring blood glucose devices

            1. 5.3.1.2.1.1 By Component (Glucometer Device, Test strips, and Lancets)

          2. 5.3.1.2.2 Continuous Glucose Monitoring

            1. 5.3.1.2.2.1 By Component (Sensors and Receivers)

        3. 5.3.1.3 Rest of North America (Value and Volume, 2016 - 2026)

          1. 5.3.1.3.1 Self-monitoring blood glucose devices

            1. 5.3.1.3.1.1 By Component (Glucometer Device, Test strips, and Lancets)

          2. 5.3.1.3.2 Continuous Glucose Monitoring

            1. 5.3.1.3.2.1 By Component (Sensors and Receivers)

      2. 5.3.2 Europe

        1. 5.3.2.1 France (Value and Volume, 2016 - 2026)

          1. 5.3.2.1.1 Self-monitoring Blood Glucose Devices

            1. 5.3.2.1.1.1 By Component (Glucometer Device, Test strips, and Lancets)

          2. 5.3.2.1.2 Continuous Glucose Monitoring

            1. 5.3.2.1.2.1 By Component (Sensors and Receivers)

        2. 5.3.2.2 Germany (Value and Volume, 2016 - 2026)

          1. 5.3.2.2.1 Self-monitoring Blood Glucose Devices

            1. 5.3.2.2.1.1 By Component (Glucometer Device, Test strips, and Lancets)

          2. 5.3.2.2.2 Continuous Glucose Monitoring

            1. 5.3.2.2.2.1 By Component (Sensors and Receivers)

        3. 5.3.2.3 Italy (Value and Volume, 2016 - 2026)

          1. 5.3.2.3.1 Self-monitoring blood glucose devices

            1. 5.3.2.3.1.1 By Component (Glucometer Device, Test strips, and Lancets)

          2. 5.3.2.3.2 Continuous Glucose Monitoring

            1. 5.3.2.3.2.1 By Component (Sensors and Receivers)

        4. 5.3.2.4 Spain (Value and Volume, 2016 - 2026)

          1. 5.3.2.4.1 Self-monitoring blood glucose devices

            1. 5.3.2.4.1.1 By Component (Glucometer Device, Test strips, and Lancets)

          2. 5.3.2.4.2 Continuous Glucose Monitoring

            1. 5.3.2.4.2.1 By Component (Sensors and Receivers)

        5. 5.3.2.5 United Kingdom (Value and Volume, 2016 - 2026)

          1. 5.3.2.5.1 Self-monitoring blood glucose devices

            1. 5.3.2.5.1.1 By Component (Glucometer Device, Test strips, and Lancets)

          2. 5.3.2.5.2 Continuous Glucose Monitoring

            1. 5.3.2.5.2.1 By Component (Sensors and Receivers)

        6. 5.3.2.6 Russia (Value and Volume, 2016 - 2026)

          1. 5.3.2.6.1 Self-monitoring blood glucose devices

            1. 5.3.2.6.1.1 By Component (Glucometer Device, Test strips, and Lancets)

          2. 5.3.2.6.2 Continuous Glucose Monitoring

            1. 5.3.2.6.2.1 By Component (Sensors and Receivers)

        7. 5.3.2.7 Rest of Europe (Value and Volume, 2016 - 2026)

          1. 5.3.2.7.1 Self-monitoring blood glucose devices

            1. 5.3.2.7.1.1 By Component (Glucometer Device, Test strips, and Lancets)

          2. 5.3.2.7.2 Continuous Glucose Monitoring

            1. 5.3.2.7.2.1 By Component (Sensors and Receivers)

      3. 5.3.3 Latin America

        1. 5.3.3.1 Mexico (Value and Volume, 2016 - 2026)

          1. 5.3.3.1.1 Self-monitoring Blood Glucose Devices

            1. 5.3.3.1.1.1 By Component (Glucometer Device, Test strips, and Lancets)

          2. 5.3.3.1.2 Continuous Glucose Monitoring

            1. 5.3.3.1.2.1 By Component (Sensors and Receivers)

        2. 5.3.3.2 Brazil (Value and Volume, 2016 - 2026)

          1. 5.3.3.2.1 Self-monitoring Blood Glucose Devices

            1. 5.3.3.2.1.1 By Component (Glucometer Device, Test strips, and Lancets)

          2. 5.3.3.2.2 Continuous Glucose Monitoring

            1. 5.3.3.2.2.1 By Component (Sensors and Receivers)

        3. 5.3.3.3 Rest of Latin America (Value and Volume, 2016 - 2026)

          1. 5.3.3.3.1 Self-monitoring Blood Glucose Devices

            1. 5.3.3.3.1.1 By Component (Glucometer Device, Test strips, and Lancets)

          2. 5.3.3.3.2 Continuous Glucose Monitoring

            1. 5.3.3.3.2.1 By Component (Sensors and Receivers)

      4. 5.3.4 Asia-Pacific

        1. 5.3.4.1 Japan (Value and Volume, 2016 - 2026)

          1. 5.3.4.1.1 Self-monitoring Blood Glucose Devices

            1. 5.3.4.1.1.1 By Component (Glucometer Device, Test strips, and Lancets)

          2. 5.3.4.1.2 Continuous Glucose Monitoring

            1. 5.3.4.1.2.1 By Component (Sensors and Receivers)

        2. 5.3.4.2 South Korea (Value and Volume, 2016 - 2026)

          1. 5.3.4.2.1 Self-monitoring Blood Glucose Devices

            1. 5.3.4.2.1.1 By Component (Glucometer Device, Test strips, and Lancets)

          2. 5.3.4.2.2 Continuous Glucose Monitoring

            1. 5.3.4.2.2.1 By Component (Sensors and Receivers)

        3. 5.3.4.3 China (Value and Volume, 2016 - 2026)

          1. 5.3.4.3.1 Self-monitoring Blood Glucose Devices

            1. 5.3.4.3.1.1 By Component (Glucometer Device, Test strips, and Lancets)

          2. 5.3.4.3.2 Continuous Glucose Monitoring

            1. 5.3.4.3.2.1 By Component (Sensors and Receivers)

        4. 5.3.4.4 India (Value and Volume, 2016 - 2026)

          1. 5.3.4.4.1 Self-monitoring Blood Glucose Devices

            1. 5.3.4.4.1.1 By Component (Glucometer Device, Test strips, and Lancets)

          2. 5.3.4.4.2 Continuous Glucose Monitoring

            1. 5.3.4.4.2.1 By Component (Sensors and Receivers)

        5. 5.3.4.5 Australia (Value and Volume, 2016 - 2026)

          1. 5.3.4.5.1 Self-monitoring Blood Glucose Devices

            1. 5.3.4.5.1.1 By Component (Glucometer Device, Test strips, and Lancets)

          2. 5.3.4.5.2 Continuous Glucose Monitoring

            1. 5.3.4.5.2.1 By Component (Sensors and Receivers)

        6. 5.3.4.6 Vietnam (Value and Volume, 2016 - 2026)

          1. 5.3.4.6.1 Self-monitoring Blood Glucose Devices

            1. 5.3.4.6.1.1 By Component (Glucometer Device, Test strips, and Lancets)

          2. 5.3.4.6.2 Continuous Glucose Monitoring

            1. 5.3.4.6.2.1 By Component (Sensors and Receivers)

        7. 5.3.4.7 Malaysia (Value and Volume, 2016 - 2026)

          1. 5.3.4.7.1 Self-monitoring Blood Glucose Devices

            1. 5.3.4.7.1.1 By Component (Glucometer Device, Test strips, and Lancets)

          2. 5.3.4.7.2 Continuous Glucose Monitoring

            1. 5.3.4.7.2.1 By Component (Sensors and Receivers)

        8. 5.3.4.8 Indonesia (Value and Volume, 2016 - 2026)

          1. 5.3.4.8.1 Self-monitoring Blood Glucose Devices

            1. 5.3.4.8.1.1 By Component (Glucometer Device, Test strips, and Lancets)

          2. 5.3.4.8.2 Continuous Glucose Monitoring

            1. 5.3.4.8.2.1 By Component (Sensors and Receivers)

        9. 5.3.4.9 Philippines (Value and Volume, 2016 - 2026)

          1. 5.3.4.9.1 Self-monitoring Blood Glucose Devices

            1. 5.3.4.9.1.1 By Component (Glucometer Device, Test strips, and Lancets)

          2. 5.3.4.9.2 Continuous Glucose Monitoring

            1. 5.3.4.9.2.1 By Component (Sensors and Receivers)

        10. 5.3.4.10 Thailand (Value and Volume, 2016 - 2026)

          1. 5.3.4.10.1 Self-monitoring Blood Glucose Devices

            1. 5.3.4.10.1.1 By Component (Glucometer Device, Test strips, and Lancets)

          2. 5.3.4.10.2 Continuous Glucose Monitoring

            1. 5.3.4.10.2.1 By Component (Sensors and Receivers)

        11. 5.3.4.11 Rest of Asia-Pacific (Value and Volume, 2016 - 2026)

          1. 5.3.4.11.1 Self-monitoring Blood Glucose Devices

            1. 5.3.4.11.1.1 By Component (Glucometer Device, Test strips, and Lancets)

          2. 5.3.4.11.2 Continuous Glucose Monitoring

            1. 5.3.4.11.2.1 By Component (Sensors and Receivers)

      5. 5.3.5 Middle-East and Africa

        1. 5.3.5.1 Saudi Arabia (Value and Volume, 2016 - 2026)

          1. 5.3.5.1.1 Self-monitoring Blood Glucose Devices

            1. 5.3.5.1.1.1 By Component (Glucometer Device, Test strips, and Lancets)

          2. 5.3.5.1.2 Continuous Glucose Monitoring

            1. 5.3.5.1.2.1 By Component (Sensors and Receivers)

        2. 5.3.5.2 Iran (Value and Volume, 2016 - 2026)

          1. 5.3.5.2.1 Self-monitoring Blood Glucose Devices

            1. 5.3.5.2.1.1 By Component (Glucometer Device, Test strips, and Lancets)

          2. 5.3.5.2.2 Continuous Glucose Monitoring

            1. 5.3.5.2.2.1 By Component (Sensors and Receivers)

        3. 5.3.5.3 Egypt (Value and Volume, 2016 - 2026)

          1. 5.3.5.3.1 Self-monitoring Blood Glucose Devices

            1. 5.3.5.3.1.1 By Component (Glucometer Device, Test strips, and Lancets)

          2. 5.3.5.3.2 Continuous Glucose Monitoring

            1. 5.3.5.3.2.1 By Component (Sensors and Receivers)

        4. 5.3.5.4 Oman (Value and Volume, 2016 - 2026)

          1. 5.3.5.4.1 Self-monitoring Blood Glucose Devices

            1. 5.3.5.4.1.1 By Component (Glucometer Device, Test strips, and Lancets)

          2. 5.3.5.4.2 Continuous Glucose Monitoring

            1. 5.3.5.4.2.1 By Component (Sensors and Receivers)

        5. 5.3.5.5 South Africa (Value and Volume, 2016 - 2026)

          1. 5.3.5.5.1 Self-monitoring Blood Glucose Devices

            1. 5.3.5.5.1.1 By Component (Glucometer Device, Test strips, and Lancets)

          2. 5.3.5.5.2 Continuous Glucose Monitoring

            1. 5.3.5.5.2.1 By Component (Sensors and Receivers)

        6. 5.3.5.6 Rest of Middle-East and Africa (Value and Volume, 2016 - 2026)

          1. 5.3.5.6.1 Self-monitoring Blood Glucose Devices

            1. 5.3.5.6.1.1 By Component (Glucometer Device, Test strips, and Lancets)

          2. 5.3.5.6.2 Continuous Glucose Monitoring

            1. 5.3.5.6.2.1 By Component (Sensors and Receivers)

  6. 6. MARKET INDICATORS

    1. 6.1 Type-1 Diabetes population (2016 - 2026)

    2. 6.2 Type-2 Diabetes population (2016 - 2026)

  7. 7. COMPETITIVE LANDSCAPE

    1. 7.1 COMPANY PROFILES

      1. 7.1.1 Abbott Diabetes Care

      2. 7.1.2 Roche Holding AG

      3. 7.1.3 LifeScan

      4. 7.1.4 Dexcom Inc.

      5. 7.1.5 Medtronic PLC

      6. 7.1.6 Arkray Inc.

      7. 7.1.7 Ascensia Diabetes Care

      8. 7.1.8 Agamatrix Inc.

      9. 7.1.9 Bionime Corporation

      10. 7.1.10 Acon Laboratories Inc.

      11. 7.1.11 Medisana AG

      12. 7.1.12 Trivida Functional Medicine

      13. 7.1.13 Rossmax International Ltd

      14. 7.1.14 Senseonics

    2. 7.2 COMPANY SHARE ANALYSIS

      1. 7.2.1 Self-monitoring Blood Glucose Devices

        1. 7.2.1.1 Abbott Diabetes Care

        2. 7.2.1.2 Roche Holding AG

        3. 7.2.1.3 LifeScan

        4. 7.2.1.4 Others

      2. 7.2.2 Continuous Glucose Monitoring Devices

        1. 7.2.2.1 Dexcom Inc.

        2. 7.2.2.2 Medtronic PLC

        3. 7.2.2.3 Abbott Diabetes Care

        4. 7.2.2.4 Others

  8. 8. MARKET OPPORTUNITIES AND FUTURE TRENDS

You can also purchase parts of this report. Do you want to check out a section wise price list?

Frequently Asked Questions

The Blood Glucose Monitoring Market market is studied from 2016 - 2027.

The Blood Glucose Monitoring Market is growing at a CAGR of 9.6% over the next 5 years.

The Blood Glucose Monitoring Market is valued at 15 Billion USD in 2016.

The Blood Glucose Monitoring Market is valued at 27 Billion USD in 2027.

North America is growing at the highest CAGR over 2021- 2026.

North America holds highest share in 2021.

Abbott Diabetes Care, Roche Holding AG, Medtronic PLC, Dexcom Inc. , LifeScan are the major companies operating in Blood Glucose Monitoring Market.

80% of our clients seek made-to-order reports. How do you want us to tailor yours?

Please enter a valid email id!

Please enter a valid message!